Skip to main content
Caplight Logo









Remedor Biomed Ltd.

Remedor Biomed Ltd.

Private
IsraelHealthcare & Life Scienceshttps://www.remedor.com/

Last Round

Grant

Jun 18, 2015

Total Funding Raised

$750,000

Company Overview

Remedor Biomed Ltd. is a biopharmaceutical company that develops topical biologic therapies for the treatment of complex skin wounds, including diabetic foot ulcers.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

diabetic foot ulcersDFUhydrogelwound healingbiopharmaceuticalchronic wound caretopical therapybiotechclinical trialswound managementadvanced wound carebiologic formulationregenerative medicine

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Remedor Biomed Ltd. Comparables

Compare Remedor Biomed Ltd. with similar companies based on industry and business-model similarity.

Remedor Biomed Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ElkosRx, LLC
82%
Aurealis Therapeutics
78%
SynDermix AG
78%

Remedor Biomed Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJun 18, 2015

Remedor Biomed Ltd. Investors

Notable investors and investment history

Remedor Biomed Ltd. investors
InvestorRounds
Israel Innovation AuthorityAccelerator
BIRD FoundationGrant
Next Generation Technology (NGT3VC)Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2015

    Received funding from the BIRD Foundation.

Remedor Biomed Ltd. Filings

Explore SEC and related filing metadata, where available.

Remedor Biomed Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Remedor Biomed Ltd.'s valuation, stock price, and market status.

Is Remedor Biomed Ltd. a public or private company?

Remedor Biomed Ltd. is a private company.

What is the current stock price of Remedor Biomed Ltd.?

Remedor Biomed Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Remedor Biomed Ltd. worth (valuation)?

Valuation information for Remedor Biomed Ltd. is not publicly available.

Can I buy Remedor Biomed Ltd. stock?

Remedor Biomed Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Remedor Biomed Ltd.'s last funding round?

Remedor Biomed Ltd.'s most recent funding round was Grant on June 18, 2015.

Who are the main investors in Remedor Biomed Ltd.?

Key investors in Remedor Biomed Ltd. include Next Generation Technology (NGT3VC).

Will Remedor Biomed Ltd. IPO soon?

No public IPO plans have been announced for Remedor Biomed Ltd..

How can I track Remedor Biomed Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Remedor Biomed Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIsrael
Employee Range6
Year Founded2009
Last FundingJun 18, 2015

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?